REG - Tristel PLC - Director Appointment

TristelAnnouncement

05/02/2019 07:05

RNS Number : 0430P
Tristel PLC
05 February 2019
 


Tristel plc
("Tristel" or the "Company")
 
Director Appointment
 
Tristel plc (AIM: TSTL), the manufacturer of infection prevention and contamination control products utilising proprietary chlorine dioxide chemistry, announces the appointment of Dr. Bruno Holthof to its Board as a non-executive director.
 
Dr. Bruno Holthof is the Chief Executive Officer of Oxford University Hospitals ("OUH"). Before OUH, he was CEO of the Antwerp Hospital Network from January 2004 until September 2015. Bruno Holthof is also Chair of the Board of Armonea, a European private care home provider.
 
Before becoming a CEO, he was a partner at McKinsey & Company. During this period, he served a wide range of healthcare clients in Europe and the United States and gained significant expertise in the areas of strategy, organisation and operations.  He holds an MBA from the Harvard Business School and an MD/PhD from the University of Leuven.
 
Commenting on the appointment, Paul Swinney, CEO of Tristel, said: "We are delighted to welcome Bruno to our Board. Bruno has more than 10 years of board level experience on publicly listed companies. He also brings to the Board an in-depth knowledge and operational experience of healthcare systems in different markets. We very much look forward to working together."
 
 
For further information please contact:       
 



Tristel plc


Tel: 01638 721 500




Paul Swinney, Chief Executive Officer








Liz Dixon, Finance Director


















Walbrook PR Ltd


Tel: 020 7933 8780 or tristel@walbrookpr.com




Paul McManus


Mob: 07980 541 893




Lianne Cawthorne


Mob: 07584 391 303














finnCap


Tel: 020 7220 0500




Geoff Nash/ Giles Rolls (Corporate Finance)








Alice Lane (Corporate Broking)












 
 
Regulatory disclosure - The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies.
 
Bruno Luc Myriam Holthof, 57, holds nil ordinary shares in the Company and nil options. Dr. Holthof current and previous directorships are as follows:
 
Current Directorships/Partnerships:
 
Project Tower Member 2 Limited
Praksis UK Ltd
Shelford Health Roundtable
Oxford University Hospital NHS Foundation Trust
Armonea Group NV
 
Directorship held in last 5 years:
 
Barco NV
BPost NV/SA
 
Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUSSKRKBAURAR